Purity 99% Ganirelix Peptides Raw Ganirelix Acetate Powder Ganirelix
Product Description
Product Details
Product Name |
Ganirelix |
Appearance |
White powder |
CAS No. |
123246-29-7 |
MF |
C80H113ClN18O13 |
MW |
1570.31902 |
Ganirelix acetate is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro fertilization.
GnRH agonists are also sometimes used in reproductive therapy, as well as to treat disorders involving sex-steroid hormones, such as endometriosis. One advantage of using GnRH antagonists is that repeated administration of GnRH agonists results in decreased levels of gonadotropins and sex steroids due to desensitization of the pituitary. This is avoided when using GnRH antagonists such as ganirelix. The success of ganirelix in reproductive therapy has been shown to be comparable to that when using GnRH agonists.
Application & Function
1. Controlled ovarian hyperstimulation (COH) for IVF: Ganirelix acetate is used in combination with other medications to regulate the menstrual cycle and prevent premature ovulation in women undergoing COH for IVF.
2. Treatment of endometriosis-related infertility: Ganirelix acetate can be used to treat infertility caused by endometriosis, a condition where tissue similar to the lining of the uterus grows outside of the uterus.
3. Treatment of uterine fibroids: Ganirelix acetate can be used to treat uterine fibroids, noncancerous growths in the uterus that can cause heavy menstrual bleeding and other complications.
4. Research purposes: Ganirelix acetate is also used in research settings to study the role of GnRH in reproductive physiology and to develop new fertility treatments.
Specification